Correlation Between Longeveron LLC and Cyclerion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Longeveron LLC and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longeveron LLC and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longeveron LLC and Cyclerion Therapeutics, you can compare the effects of market volatilities on Longeveron LLC and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longeveron LLC with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longeveron LLC and Cyclerion Therapeutics.
Diversification Opportunities for Longeveron LLC and Cyclerion Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Longeveron and Cyclerion is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Longeveron LLC and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and Longeveron LLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longeveron LLC are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of Longeveron LLC i.e., Longeveron LLC and Cyclerion Therapeutics go up and down completely randomly.
Pair Corralation between Longeveron LLC and Cyclerion Therapeutics
Given the investment horizon of 90 days Longeveron LLC is expected to under-perform the Cyclerion Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Longeveron LLC is 6.13 times less risky than Cyclerion Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Cyclerion Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 264.00 in Cyclerion Therapeutics on September 3, 2024 and sell it today you would lose (44.00) from holding Cyclerion Therapeutics or give up 16.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Longeveron LLC vs. Cyclerion Therapeutics
Performance |
| Timeline |
| Longeveron LLC |
| Cyclerion Therapeutics |
Longeveron LLC and Cyclerion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Longeveron LLC and Cyclerion Therapeutics
The main advantage of trading using opposite Longeveron LLC and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longeveron LLC position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.| Longeveron LLC vs. DiaMedica Therapeutics | Longeveron LLC vs. Lyra Therapeutics | Longeveron LLC vs. Centessa Pharmaceuticals PLC |
| Cyclerion Therapeutics vs. Kronos Bio | Cyclerion Therapeutics vs. Larimar Therapeutics | Cyclerion Therapeutics vs. Addex Therapeutics | Cyclerion Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |